Data protection Impressum

Technology Park

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (June 2024)

26 June 2024

Sproudz, a new production hub in Zollikofen, offers start-ups in the food industry space and equipment for producing innovative plant-based products.

Fenaco launches Sproudz, a flexible production hub for food start-ups in Zollikofen

25 June 2024

iOnctura has secured EUR 80 million in a Series B funding round to advance innovative cancer therapies, with a focus on neglected cancers such as uveal melanoma.

iOnctura secures EUR 80 million Series B financing to advance cancer treatments

25 June 2024

Dandelion Science and the Wyss Center Geneva have announced a partnership to develop a generative AI platform for non-invasive brain therapies.

Dandelion Science partners with Wyss Center to pioneer AI-based brain therapies

12 June 2024

The Tech4Trust program awarded Brightside AI as the top start-up in its season 5 finale, celebrating its exceptional contributions to digital trust and security.

Brightside AI wins top prize at the Tech4Trust 2024 awards

11 June 2024

BlueArk and HES-SO Valais-Wallis have signed a five-year agreement to create STREAM, a research lab focused on innovative water management solutions.

BlueArk and HES-SO Valais-Wallis launch a new water management research hub

11 June 2024

EPFL and the Valais cantonal government signed an agreement to create a new hub for energy transition research, adding six research chairs by 2032.

EPFL to establish six new research chairs in Valais by 2032

10 June 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (May 2024)

28 May 2024

HeroSupport and Calico Biosystems join Tech4Eva, a six-month equity-free accelerator dedicated to advancing women’s health technologies globally.

HeroSupport and Calico Biosystems selected for the Tech4Eva accelerator program

15 May 2024

EP Equity Investment (EPEI), a company dedicated to investing in promising European companies, has acquired a 24.99% stake in Nanobacterie to advance the development of innovative treatments for prostate cancer.

Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment

6 May 2024

1 … 5 6 7 8 9 10 11 12 13 … 22